AOD-9604 5mg
AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) with a tyrosine modification. It stimulates lipolysis and inhibits lipogenesis without the growth-promoting or diabetogenic effects of full HGH. Clinical trials demonstrated fat reduction, and it received GRAS status from the FDA for use in food products.
Sequence
Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (modified HGH 176-191)
Market avg: $49.99 — save 36%
Volume pricing
Pay with USDC via Coinbase Commerce
Certificate of Analysis
Independently verified by Janoshik Analytical
Test ID
JAN-AOD-2026-001
Purity
99%
Method
HPLC-MS
Batch
AOD-2026-01A
Test Date
February 1, 2026
Identity
Confirmed
Storage Requirements
Lyophilized
2-8°C, protect from light
Reconstituted
2-8°C, use within 21 days
Modified HGH fragment with enhanced stability. Reconstitute with bacteriostatic water.
Published Research
2 peer-reviewed studies
AOD9604 stimulates lipolysis via a growth hormone-independent mechanism
Heffernan MA, Thorburn AW, Fam B, et al. — Obesity Research, 2001
Study demonstrating AOD-9604 lipolytic mechanism independent of GH receptor activation.
Anti-obesity effects of the metabolic fragment of human growth hormone
Ng FM, Sun J, Sharma L, et al. — Endocrinology, 2000
Research on the anti-obesity properties of the HGH 176-191 fragment.
Related Products
Research use only. All products are sold strictly for in-vitro research purposes only. Not for human consumption. Information provided references published research literature. No medical claims are made or implied.